Global Gastric Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Description
Global Gastric Cancer Diagnostics Market - Industry Trends and Forecast to 2030
The global gastric cancer diagnostics market is projected to register a CAGR of 8.7% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation:
Global Gastric Cancer Diagnostics Market, By Product Type (Instruments, Reagents & Consumables, Services), Diagnostics Type (Gastric (Pre) Cancer Screening Tests/Physical Exam, Confirmatory Tests), Age Group (Adult, Pediatric, and Geriatrics), Type (Intestinal Or Diffuse Adenocarcinoma, Carcinoid Tumor, Gastrointestinal Stromal Tumor (GIST), Gastric Lymphoma and Others), Stage (Stage 0, Stage I, Stage II, Stage III), Gender (Male and Female), Sample Type (Blood, Tissue, Urine, and Stool), End Users (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Ireland, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East And Africa, Brazil, Argentina, and Rest of South America) Industry Trends and Forecast To 2030
Some of the major factors contributing to the growth of the gastric cancer diagnostics market are:
• Rising healthcare expenditure for better health services
• Rising Awareness about gastric cancer
• Increase in diagnostic procedures for gastric cancer
Market Players:
Some of the key market players in the global gastric cancer diagnostics market are listed below:
• BIOMÉRIEUX
• Myriad Genetics, Inc.
• ACON Laboratories, Inc.
• Teco Diagnostics
• Vela Diagnostics
• Abbott
• AdvaCare Pharma
• MiRXES
• Fujirebio (An H.U. Group company)
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• GENERAL ELECTRIC COMPANY
• Agilent Technologies, Inc.
• Endofotonics Pte Ltd
• Biohit Oyj
• BIOCEPT, INC.
• FOUNDATION MEDICINE, INC.
• DiaSorin S.p.A
• Paragon Genomics, Inc.
• QIAGEN
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
The global gastric cancer diagnostics market is projected to register a CAGR of 8.7% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation:
Global Gastric Cancer Diagnostics Market, By Product Type (Instruments, Reagents & Consumables, Services), Diagnostics Type (Gastric (Pre) Cancer Screening Tests/Physical Exam, Confirmatory Tests), Age Group (Adult, Pediatric, and Geriatrics), Type (Intestinal Or Diffuse Adenocarcinoma, Carcinoid Tumor, Gastrointestinal Stromal Tumor (GIST), Gastric Lymphoma and Others), Stage (Stage 0, Stage I, Stage II, Stage III), Gender (Male and Female), Sample Type (Blood, Tissue, Urine, and Stool), End Users (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Ireland, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East And Africa, Brazil, Argentina, and Rest of South America) Industry Trends and Forecast To 2030
Some of the major factors contributing to the growth of the gastric cancer diagnostics market are:
• Rising healthcare expenditure for better health services
• Rising Awareness about gastric cancer
• Increase in diagnostic procedures for gastric cancer
Market Players:
Some of the key market players in the global gastric cancer diagnostics market are listed below:
• BIOMÉRIEUX
• Myriad Genetics, Inc.
• ACON Laboratories, Inc.
• Teco Diagnostics
• Vela Diagnostics
• Abbott
• AdvaCare Pharma
• MiRXES
• Fujirebio (An H.U. Group company)
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• GENERAL ELECTRIC COMPANY
• Agilent Technologies, Inc.
• Endofotonics Pte Ltd
• Biohit Oyj
• BIOCEPT, INC.
• FOUNDATION MEDICINE, INC.
• DiaSorin S.p.A
• Paragon Genomics, Inc.
• QIAGEN
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
419 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Global Gastric Cancer Diagnostics Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Market End Coverage Grid
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insight
- 4.1 Pestel's Model
- 4.2 Porter's 5 Forces
- 4.3 Epidemiology
- 4.4 Brand Analysis
- 4.5 Role Of Artificial Intelligence (Ai) And Machine Learning (Ml): Global Gastric Cancer Diagnostics Market
- 4.6 Industry Insights:
- 5 Global Gastric Cancer Diagnostics Market, Regulatory
- 5.1 North America
- 5.1.1 Regulatory Scenario In The U.S
- 5.2 European Union (Eu)-
- 5.3 Asia-pacific
- 5.3.1 Regulatory Scenario In Australia-
- 5.3.2 Regulatory Scenario In Japan
- 5.3.3 Regulatory Scenario In China
- 5.3.4 Regulatory Scenario In Singapore-
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Increase In Incidence Of Gastrointestinal Tumours, Lymphoma, And Adenocarcinoma
- 6.1.2 Rise In Alcohol Consumption And Surge In Smoking
- 6.1.3 Increase In The Geriatric Population
- 6.1.4 Recent Advancements In Gastric Cancer Diagnostics Products
- 6.2 Restraints
- 6.2.1 High Cost Of Gastric Cancer Diagnostic Test
- 6.2.2 Lack Of Sufficient Financial Support From Health Insurance Policies
- 6.3 Opportunities
- 6.3.1 Rise In The Adoption Of Automated Systems
- 6.3.2 Increased Research And Development On Cancer Diagnostics Products
- 6.3.3 Strategic Initiatives By Emerging Players
- 6.4 Challenges
- 6.4.1 Stringent Regulations And Policies For Approving The Complicated Nature Of Radiation Devices
- 6.4.2 Limitations Of Radiation Tests
- 7 Global Gastric Cancer Diagnostics Market, By Product Type
- 7.1 Overview
- 7.2 Reagents & Consumables
- 7.2.1 Kits
- 7.2.1.1 Dna Polymerase Kits
- 7.2.1.2 Pcr Kits
- 7.2.1.3 Nucleic Acid Isolation Kits
- 7.2.1.4 Others
- 7.2.2 Reagents
- 7.2.2.1 Assays
- 7.2.2.2 Buffers
- 7.2.2.3 Primers
- 7.2.2.4 Others
- 7.3 Instruments
- 7.4 Services
- 8 Global Gastric Cancer Diagnostics Market, By Diagnostic Type
- 8.1 Overview
- 8.2 Confirmatory Test
- 8.2.1 Imaging Tests
- 8.2.1.1 Pet Scan/Ct Scan
- 8.2.1.2 Ct Scan
- 8.2.1.3 Ultrasound
- 8.2.1.4 Mri
- 8.2.1.5 X-ray
- 8.2.2 Biomarker
- 8.2.2.1 Dna Biomarker
- 8.2.2.2 Rna Biomarker
- 8.2.2.3 Protein Biomarker
- 8.2.3 Biopsy
- 8.3 Gastric Cancer Screening Tests/Physical Exam
- 9 Global Gastric Cancer Diagnostics Market, By Age Group
- 9.1 Overview
- 9.2 Geriatrics
- 9.3 Adult
- 9.4 Pediatric
- 10 Global Gastric Cancer Diagnostics Market, By Disease Type
- 10.1 Overview
- 10.2 Intestinal Or Diffuse Adenocarcinoma
- 10.3 Carcinoid Tumor
- 10.4 Gastrointestinal Stromal Tumor
- 10.5 Gastric Lymphoma
- 10.6 Others
- 11 Global Gastric Cancer Diagnostics Market, By Stage
- 11.1 Overview
- 11.2 Stage I
- 11.2.1 Stage Ia
- 11.2.2 Stage Ib
- 11.3 Stage Ii
- 11.3.1 Stage Iia
- 11.3.2 Stage Iib
- 11.4 Stage Iii
- 11.4.1 Stage Iiia
- 11.4.2 Stage Iiib
- 11.4.3 Stage Iiic
- 11.5 Stage 0
- 12 Global Gastric Cancer Diagnostics Market, By Gender
- 12.1 Overview
- 12.2 Male
- 12.3 Female
- 13 Global Gastric Cancer Diagnostics Market, By Sample Type
- 13.1 Overview
- 13.2 Stool
- 13.3 Tissue
- 13.4 Blood
- 13.5 Urine
- 14 Global Gastric Cancer Diagnostics Market, By End User
- 14.1 Overview
- 14.2 Hospitals
- 14.3 Diagnostic Laboratories
- 14.4 Cancer Research Institutes
- 14.5 Oncology Specialty Clinics
- 14.6 Others
- 15 Global Gastric Cancer Diagnostics Market, By Distribution Channel
- 15.1 Overview
- 15.2 Direct Tenders
- 15.3 Retail Sales
- 16 Global Gastric Cancer Diagnostics Market, By Region
- 16.1 Overview
- 16.2 North America
- 16.2.1 U.S.
- 16.2.2 Canada
- 16.2.3 Mexico
- 16.3 Europe
- 16.3.1 Germany
- 16.3.2 France
- 16.3.3 U.K
- 16.3.4 Russia
- 16.3.5 Italy
- 16.3.6 Spain
- 16.3.7 Belgium
- 16.3.8 Netherlands
- 16.3.9 Turkey
- 16.3.10 Switzerland
- 16.3.11 Rest Of Europe
- 16.4 Asia-pacific
- 16.4.1 South Korea
- 16.4.2 Japan
- 16.4.3 China
- 16.4.4 Australia
- 16.4.5 Singapore
- 16.4.6 India
- 16.4.7 Thailand
- 16.4.8 Malaysia
- 16.4.9 Indonesia
- 16.4.10 Philippines
- 16.4.11 Rest Of Asia-pacific
- 16.5 South America
- 16.5.1 Brazil
- 16.5.2 Argentina
- 16.5.3 Rest Of South America
- 16.6 Middle East And Africa
- 16.6.1 South Africa
- 16.6.2 Saudi Arabia
- 16.6.3 U.A.E
- 16.6.4 Egypt
- 16.6.5 Israel
- 16.6.6 Rest Of Middle East And Africa
- 17 Global Gastric Cancer Diagnostics Market, Company Landscape
- 17.1 Company Share Analysis: Global
- 17.2 Company Share Analysis: North America
- 17.3 Company Share Analysis: Europe
- 17.4 Company Share Analysis: Asia-pacific
- 18 Swot Analysis
- 19 Company Profile
- 19.1 F. Hoffmann-la Roche Ltd
- 19.1.1 Company Snapshot
- 19.1.2 Revenue Analysis
- 19.1.3 Company Share Analysis
- 19.1.4 Product Portfolio
- 19.1.5 Recent Development
- 19.2 General Electric
- 19.2.1 Company Snapshot
- 19.2.2 Revenue Analysis
- 19.2.3 Company Share Analysis
- 19.2.4 Product Portfolio
- 19.2.5 Recent Development
- 19.3 Abbott
- 19.3.1 Company Snapshot
- 19.3.2 Revenue Analysis
- 19.3.3 Company Share Analysis
- 19.3.4 Product Portfolio
- 19.3.5 Recent Development
- 19.4 Qiagen
- 19.4.1 Company Snapshot
- 19.4.2 Revenue Analysis
- 19.4.3 Company Share Analysis
- 19.4.4 Product Portfolio
- 19.4.5 Recent Development
- 19.5 Myriad Genetics, Inc.
- 19.5.1 Company Snapshot
- 19.5.2 Revenue Analysis
- 19.5.3 Company Share Analysis
- 19.5.4 Product Portfolio
- 19.5.5 Recent Development
- 19.6 Acon Laboratories, Inc.
- 19.6.1 Company Snapshot
- 19.6.2 Product Portfolio
- 19.6.3 Recent Development
- 19.7 Advacare Pharma
- 19.7.1 Company Snapshot
- 19.7.2 Product Portfolio
- 19.7.3 Recent Development
- 19.8 Agilent Technologies, Inc.
- 19.8.1 Company Snapshot
- 19.8.2 Revenue Analysis
- 19.8.3 Product Portfolio
- 19.8.4 Recent Developments
- 19.9 Biomérieux
- 19.9.1 Company Snapshot
- 19.9.2 Revenue Analysis
- 19.9.3 Product Portfolio
- 19.9.4 Recent Development
- 19.10 Biocept, Inc.
- 19.10.1 Company Snapshot
- 19.10.2 Revenue Analysis
- 19.10.3 Product Portfolio
- 19.10.4 Recent Development
- 19.11 Biohit Oyj
- 19.11.1 Company Snapshot
- 19.11.2 Revenue Analysis
- 19.11.3 Product Portfolio
- 19.11.4 Recent Development
- 19.12 Diasorin S.P.A
- 19.12.1 Company Snapshot
- 19.12.2 Revenue Analysis
- 19.12.3 Product Portfolio
- 19.12.4 Recent Development
- 19.13 Endofotonics Pte Ltd
- 19.13.1 Company Snapshot
- 19.13.2 Product Portfolio
- 19.13.3 Recent Development
- 19.14 Foundation Medicine, Inc.
- 19.14.1 Company Snapshot
- 19.14.2 Product Portfolio
- 19.14.3 Recent Developments
- 19.15 Fujirebio (An H.U. Group Company)
- 19.15.1 Company Snapshot
- 19.15.2 Revenue Analysis
- 19.15.3 Product Portfolio
- 19.15.4 Recent Development 407
- List Of Tables
- Table 1 Approved Companion Diagnostic Device
- Table 2 The Below-mentioned List Shows The Cost Of Pet Scan For Cancer Diagnosis In Different Regions Across The Globe-
- Table 3 Global Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 4 Global Reagents & Consumables In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 5 Global Reagent And Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 6 Global Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 7 Global Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 8 Global Instruments In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 9 Global Services In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 10 Global Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 11 Global Confirmatory Test In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 12 Global Confirmatory Test In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 13 Global Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 14 Global Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 15 Global Gastric Cancer Screening Tests/Physical Exam In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 16 Global Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 17 Global Geriatrics In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 18 Global Adult In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 19 Global Pediatric In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 20 Global Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 21 Global Intestinal Or Diffuse Adenocarcinoma In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 22 Global Carcinoid Tumor In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 23 Global Gastrointestinal Stromal Tumor In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 24 Global Gastric Lymphoma In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 25 Global Others In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 26 Global Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 27 Global Stage I In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 28 Global Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 29 Global Stage Ii In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 30 Global Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 31 Global Stage Iii In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 32 Global Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 33 Global Stage 0 In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 34 Global Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 35 Global Male In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 36 Global Female In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 37 Global Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 38 Global Stool In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 39 Global Tissue In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 40 Global Blood In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 41 Global Urine In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 42 Global Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 43 Global Hospitals In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 44 Global Diagnostic Laboratories In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 45 Global Cancer Research Institutes In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 46 Global Oncology Specialty Clinics In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 47 Global Others In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 48 Global Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 49 Global Direct Tenders In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 50 Global Retail Sales In Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 51 Global Gastric Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
- Table 52 North America Gastric Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
- Table 53 North America Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 54 North America Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 55 North America Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 56 North America Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 57 North America Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 58 North America Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 59 North America Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 60 North America Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 61 North America Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 62 North America Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 63 North America Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 64 North America Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 65 North America Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 66 North America Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 67 North America Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 68 North America Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 69 North America Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 70 North America Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 71 U.S. Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 72 U.S. Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 73 U.S. Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 74 U.S. Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 75 U.S. Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 76 U.S. Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 77 U.S. Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 78 U.S. Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 79 U.S. Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 80 U.S. Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 81 U.S. Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 82 U.S. Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 83 U.S. Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 84 U.S. Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 85 U.S. Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 86 U.S. Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 87 U.S. Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 88 U.S. Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 89 Canada Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 90 Canada Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 91 Canada Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 92 Canada Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 93 Canada Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 94 Canada Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 95 Canada Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 96 Canada Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 97 Canada Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 98 Canada Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 99 Canada Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 100 Canada Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 101 Canada Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 102 Canada Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 103 Canada Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 104 Canada Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 105 Canada Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 106 Canada Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 107 Mexico Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 108 Mexico Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 109 Mexico Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 110 Mexico Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 111 Mexico Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 112 Mexico Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 113 Mexico Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 114 Mexico Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 115 Mexico Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 116 Mexico Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 117 Mexico Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 118 Mexico Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 119 Mexico Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 120 Mexico Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 121 Mexico Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 122 Mexico Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 123 Mexico Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 124 Mexico Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 125 Europe Surgical Power Tools Market, By Country, 2021-2030 (Usd Million)
- Table 126 Europe Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 127 Europe Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 128 Europe Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 129 Europe Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 130 Europe Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 131 Europe Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 132 Europe Imaging Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 133 Europe Biomarker In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 134 Europe Gastric Cancer Diagnostics Market, By Age Group, 2021-2030 (Usd Million)
- Table 135 Europe Gastric Cancer Diagnostics Market, By Disease Type, 2021-2030 (Usd Million)
- Table 136 Europe Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 137 Europe Stage I In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 138 Europe Stage Ii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 139 Europe Stage Iii In Gastric Cancer Diagnostics Market, By Stage, 2021-2030 (Usd Million)
- Table 140 Europe Gastric Cancer Diagnostics Market, By Gender, 2021-2030 (Usd Million)
- Table 141 Europe Gastric Cancer Diagnostics Market, By Sample Type, 2021-2030 (Usd Million)
- Table 142 Europe Gastric Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
- Table 143 Europe Gastric Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
- Table 144 Germany Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 145 Germany Reagents & Consumables In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 146 Germany Kits In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 147 Germany Reagents In Gastric Cancer Diagnostics Market, By Product Type, 2021-2030 (Usd Million)
- Table 148 Germany Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- Table 149 Germany Confirmatory Tests In Gastric Cancer Diagnostics Market, By Diagnostic Type, 2021-2030 (Usd Million)
- List Of Figures
- Figure 1 Global Gastric Cancer Diagnostics Market: Segmentation
- Figure 2 Global Gastric Cancer Diagnostics Market: Data Triangulation
- Figure 3 Global Gastric Cancer Diagnostics Market: Droc Analysis
- Figure 4 Global Gastric Cancer Diagnostics Market: Global Vs. Regional Market Analysis
- Figure 5 Global Gastric Cancer Diagnostics Market: Company Research Analysis
- Figure 6 Global Gastric Cancer Diagnostics Market: Multivariate Modelling
- Figure 7 Global Gastric Cancer Diagnostics Market: Interview Demographics
- Figure 8 Global Gastric Cancer Diagnostics Market: Dbmr Market Position Grid
- Figure 9 Global Gastric Cancer Diagnostics Market: Vendor Share Analysis
- Figure 10 Global Gastric Cancer Diagnostics Market: Market End Coverage Grid
- Figure 11 Global Gastric Cancer Diagnostics Market: Segmentation
- Figure 12 North America Is Expected To Dominate The Global Gastric Cancer Diagnostics Market, And Asia-pacific Is Expected To Grow With The Highest Cagr In The Forecast Period Of 2023 To 2030
- Figure 13 Increase In The Incidence Of Gastrointestinal Tumors, Lymphoma, And Adenocarcinoma Is Expected To Drive The Global Gastric Cancer Diagnostics Market Growth In The Forecast Period Of 2023 To 2030
- Figure 14 Reagents And Consumables Segment Is Expected To Account For The Largest Share Of The Global Gastric Cancer Diagnostics Market In 2023 & 2030
- Figure 15 Asia–pacific Is The Fastest-growing Market For The Gastric Cancer Diagnostics Manufacturers In The Forecast Period Of 2023 To 2030
- Figure 16 Drivers, Restraints, Opportunities, And Challenges, Of The Global Gastric Cancer Diagnostics Market
- Figure 17 Global Gastric Cancer Diagnostics Market: By Product Type, 2022
- Figure 18 Global Gastric Cancer Diagnostics Market: By Product Type, 2023-2030 (Usd Million)
- Figure 19 Global Gastric Cancer Diagnostics Market: By Product Type, Cagr (2023-2030)
- Figure 20 Global Gastric Cancer Diagnostics Market: By Product Type, Lifeline Curve
- Figure 21 Global Gastric Cancer Diagnostics Market: By Diagnostic Type, 2022
- Figure 22 Global Gastric Cancer Diagnostics Market: By Diagnostic Type, 2023-2030 (Usd Million)
- Figure 23 Global Gastric Cancer Diagnostics Market: By Diagnostic Type, Cagr (2023-2030)
- Figure 24 Global Gastric Cancer Diagnostics Market: By Diagnostic Type, Lifeline Curve
- Figure 25 Global Gastric Cancer Diagnostics Market: By Age Group, 2022
- Figure 26 Global Gastric Cancer Diagnostics Market: By Age Group, 2023-2030 (Usd Million)
- Figure 27 Global Gastric Cancer Diagnostics Market: By Age Group, Cagr (2023-2030)
- Figure 28 Global Gastric Cancer Diagnostics Market: By Age Group, Lifeline Curve
- Figure 29 Global Gastric Cancer Diagnostics Market: By Disease Type, 2022
- Figure 30 Global Gastric Cancer Diagnostics Market: By Disease Type, 2023-2030 (Usd Million)
- Figure 31 Global Gastric Cancer Diagnostics Market: By Disease Type, Cagr (2023-2030)
- Figure 32 Global Gastric Cancer Diagnostics Market: By Disease Type, Lifeline Curve
- Figure 33 Global Gastric Cancer Diagnostics Market: By Stage, 2022
- Figure 34 Global Gastric Cancer Diagnostics Market: By Stage, 2023-2030 (Usd Million)
- Figure 35 Global Gastric Cancer Diagnostics Market: By Stage, Cagr (2023-2030)
- Figure 36 Global Gastric Cancer Diagnostics Market: By Stage, Lifeline Curve
- Figure 37 Global Gastric Cancer Diagnostics Market: By Gender, 2022
- Figure 38 Global Gastric Cancer Diagnostics Market: By Gender, 2023-2030 (Usd Million)
- Figure 39 Global Gastric Cancer Diagnostics Market: By Gender, Cagr (2023-2030)
- Figure 40 Global Gastric Cancer Diagnostics Market: By Gender, Lifeline Curve
- Figure 41 Global Gastric Cancer Diagnostics Market: By Sample Type, 2022
- Figure 42 Global Gastric Cancer Diagnostics Market: By Sample Type, 2023-2030 (Usd Million)
- Figure 43 Global Gastric Cancer Diagnostics Market: By Sample Type, Cagr (2023-2030)
- Figure 44 Global Gastric Cancer Diagnostics Market: By Sample Type, Lifeline Curve
- Figure 45 Global Gastric Cancer Diagnostics Market: By End User, 2022
- Figure 46 Global Gastric Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
- Figure 47 Global Gastric Cancer Diagnostics Market: By End User, Cagr (2023-2030)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
